• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The effectiveness of prostaglandin as anticancer agents and the expression of the transporter in urological cancer

Research Project

Project/Area Number 11671544
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Urology
Research InstitutionYamanashi Medical University

Principal Investigator

TSUCHIDA Takayuki  medical department of urology, research associate, 医学部, 助手 (30217327)

Co-Investigator(Kenkyū-buntansha) KANAI Naoaki  Toukai University department of development engineering assistant professor, 開発工学部, 助教授 (40194881)
Project Period (FY) 1999 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥3,400,000 (Direct Cost: ¥3,400,000)
Fiscal Year 2000: ¥1,700,000 (Direct Cost: ¥1,700,000)
Fiscal Year 1999: ¥1,700,000 (Direct Cost: ¥1,700,000)
Keywordsprostaglandin transporter / cyclopentenon / PGT / hPGT / シクロペンテノン型プロスタグランジン
Research Abstract

A HeLa cell introduced complementary DNA of human prostaglandin transporter (following PGT) which identified, and we made a PGT stable expressed cells (HeLa cells). This time investigated affinity of cyclopentenon of PG type for PGT, but a value of comparatively high affinity (1.5uM) is provided. And it suggested cyclopentenons is crowded a cell by PGT.Cyclopentenons were taken in a cell, and caused cell death and were attracted attention as anticancer drug.
The possibility that PGT participated in Cyclopentenons taken in the cell was suggested. So with Flowcytometer, we confirmed whether a PGT stable expression cells became growth restraint or cell death by cyclopentenon (PGA1) of the various density (2uM, 5uM, 10uM, 20uM, 50uM). As for the result, the density of PGA1 was not less than 20uM, and cell death was identified as a PGT stable expressed cells and control HeLa cells on cell division G1.Control cells that PGT were not expressed became cell death and the PGA1 affinity for PGT was 1.5uM, and so, that cell death were observed by high PGA1s density of not less than 20uM.As for the fact a transporter except PGT is suggested the possibility of the existing. In physiological, the lung and the kidney have PGT expressed a lot and we made lung cancer cells and renal cancer cells of PGT expressed a lot in order to make it clear experimentally. As the result cell death was recognized with high density than the affinity for PGT.And so we investigated for other cyclopentenons, cell death still happened with high density than the affinity of other cyclopentenons, and cell death was generated with the control cells that PGT were not expressed. There is possibility participating in growth restraint, but the influence is strong to a normal cell, and it is suggested that cyclopentenons is anticancer agents had the strong side effect. .

Report

(3 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report

Research Products

(6 results)

All Other

All Publications (6 results)

  • [Publications] 土田孝之: "泌尿器科における腹腔鏡手術の経験"山梨医学. 28. 264-267 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 土田孝之: "ヒトプロスタグランジントランスポーター(hPGT)分子の性質から得られたPG製剤に有用な構造の検討"山梨医科大学雑誌. 14. 7-16 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Takayuki Tsuchida: "Structural determinants of substrates for the human prostaglandin transporter (hPGT)"Yamanashi Medical Journal. 14. 7-16 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 土田孝之: "泌尿器科における腹腔鏡手術の経験"山梨医学. 28. 264-267 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 土田孝之: "ヒトプロスタグランジントランスポーター(hPGT)分子の性質から得られたPG製剤に有用な構造の検討"山梨医科大学雑誌. 14. 7-16 (1999)

    • Related Report
      2000 Annual Research Report
  • [Publications] 土田孝之: "ヒトプロスタグランジントランスポーター(hPGT)分子の性質から得られたPG製剤に有用な構造の検討"Yamanashi Medical Journal. 14. 7-16 (1999)

    • Related Report
      1999 Annual Research Report

URL: 

Published: 1999-03-31   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi